
Loading, please wait...

Loading, please wait...

Lipedema is a chronic adipose disorder often associated with significant physical impairments and reduced quality of life. While conservative treatments are the mainstay of management, the role of rESWT for lipedema has recently gained attention. A prospective within-patient study now provides evidence regarding its impact on clinical and imaging outcomes.
Researchers evaluated twelve women with clinically diagnosed lipedema who underwent six sessions of radial extracorporeal shock wave therapy. One limb received treatment, while the other served as an internal control. Consequently, this design allowed for a direct comparison of tissue changes. The participants were assessed at baseline, six weeks, and three months post-treatment.
The results showed significant improvements in functional capacity and physical activity levels. Moreover, quality of life scores improved significantly compared to baseline measurements. Ultrasound and elastography data revealed a measurable decrease in subcutaneous tissue thickness. However, the most notable finding was the reduction in tissue stiffness at predefined leg and thigh sites.
Additionally, segmental bioimpedance analysis demonstrated better fluid distribution within the treated limbs. These findings suggest that shock wave therapy potentially improves the microenvironment of the adipose tissue. Therefore, clinicians might consider this non-invasive therapy as a beneficial adjunct to standard protocols like compression and exercise.
Radial extracorporeal shock wave therapy delivers mechanical energy to the tissues. This process may stimulate microcirculation and help reduce the thickness of fibrotic adipose layers commonly found in lipedema.
The study reported significant gains in functional capacity and physical activity levels. Patients also reported a marked improvement in their general health-related quality of life over the three-month follow-up period.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider for any medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Novo Rigueiro M et al. Clinical, ultrasound, elastography and bioimpedance changes after radial extracorporeal shock wave therapy in patients with lipedema: A prospective within-patient study. Phlebology. 2026 May 11. doi: 10.1177/02683555261451555. PMID: 42109195.
Michelini S, Musa F, Vetrano M, et al. Defocused and radial shock wave therapy, mesotherapy, and kinesio taping effects in patients with lipedema: a pilot study. Lymphology. 2023;56(1):13-26. PMID: 38019876.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A prospective study shows radial extracorporeal shock wave therapy (rESWT) improves functional capacity, quality of life, and tissue thickness in lipedema....
5 months ago

As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today

A comparative cohort study evaluates vNOTES vs TLH hysterectomy for benign conditions, demonstrating shorter operative duration, faster return to daily activities, and equivalent female sexual function scores without increased dyspareunia.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today